# OnCo record nct05440786 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05440786/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05440786", "NCT05440786" ;
  schema:name "CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma"@en ;
  schema:alternateName "CAMPFIRE"@en ;
  schema:description "A phase 2 trial of Abemaciclib and Temozolomide in ewing sarcoma, run by Eli Lilly and Company, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05440786/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05440786> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-09-20" ;
  onco:cancers <https://onco.cc/cancers/ewing-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/abemaciclib/>, <https://onco.cc/drugs/temozolomide/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> .